If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.
Rhinopront Side Effects Reported to FDA
Rhinopront Side Effect Report#5015788-9 Rash Maculo-papular, Skin Test Positive
This is a report of a 66-year-old female patient (weight: NA) from Germany, suffering from the following health symptoms/conditions: nasopharyngitis, who was treated with Rhinopront Kombi (pseudoephedrine, Triprolidine) (dosage: 1 Tablet Daily, Oral, start time:
Jan 15, 2005), combined with:
Codipront /old Form/ (codeine, Phenyltoloxamine)
Ambroxol Hydrochloride (ambroxol Hydrochloride)
and developed a serious reaction and side effect(s): Rash Maculo-papular, Skin Test Positive after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Rhinopront Kombi (pseudoephedrine, Triprolidine) treatment in female patients, resulting in Rash Maculo-papular side effect.
Rhinopront Side Effect Report#4603902-6 Back Disorder, Dizziness, Loss Of Consciousness
This report suggests a potential Rhinopront Kombi(pseudoephedrine, Triprolidine)Back Disorder side effect(s) that can have serious consequences. A 35-year-old male patient (weight: NA) from was diagnosed with the following symptoms/conditions: NA and used Rhinopront Kombi(pseudoephedrine, Triprolidine) (dosage: 1 Tablet Twice, Oral) starting
Feb 15, 2005. After starting Rhinopront Kombi(pseudoephedrine, Triprolidine) the patient began experiencing various side effects, including: Back Disorder, Dizziness, Loss Of ConsciousnessAdditional drugs used concurrently: NA. Although Rhinopront Kombi(pseudoephedrine, Triprolidine) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Back Disorder, may still occur.
Rhinopront Side Effect Report#4596292-9 Rash Maculo-papular
This Rash Maculo-papular problem was reported by a physician from . A 66-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: feeling cold. On
Jan 15, 2005 this consumer started treatment with Rhinopront Kombi (pseudoephedrine, Triprolidine) (dosage: Oral). The following drugs were being taken at the same time:
Codipront/old Form/(codeine, Phenyltoloxamine)
Ambroxol Hydrochloride(ambroxol Hydrochloride)
When using Rhinopront Kombi (pseudoephedrine, Triprolidine), the patient experienced the following unwanted symptoms/side effects: Rash Maculo-papularAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Rash Maculo-papular, may become evident only after a product is in use by the general population.
Rhinopront Side Effect Report#4544444-6 Rash Maculo-papular
This Rash Maculo-papular side effect was reported by a physician from . A 54-year-old female patient (weight:NA) experienced the following symptoms/conditions: nasopharyngitis.The patient was prescribed Rhinopront Kombi (pseudoephedrine, Triprolidine) (drug dosage: 2 Tablets Tid, Oral), which was initiated on
Oct 01, 2003. Concurrently used drugs:
.After starting to take Rhinopront Kombi (pseudoephedrine, Triprolidine) the consumer reported adverse symptoms, such as: Rash Maculo-papularThese side effects may potentially be related to Rhinopront Kombi (pseudoephedrine, Triprolidine). The patient was hospitalized.
The appearance of Rhinopront on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
What are common Rhinopront Side Effects for Women?
It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.
Why Your Notes are Important
Your notes could be helpful in several ways:
You can use them to remind you of details that may alert your health care professional(s) to a problem
You will have a record to refer to in the future, in case you are ever prescribed the same medicine again
You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.
Medicine Name and Dosage:
Date & Time
Other Medicine(s) or Treatment(s)
Scale: 1 = very mild to 10 = very bad
Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Rhinopront reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.